Transferrin receptor

Last updated on: 01.07.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

General informationThis section has been translated automatically.

The soluble transferrin receptor (sTfR) is formed as a result of proteolytic cleavage of the membrane-bound molecule. In plasma, the soluble transferrin receptor is present together with transferrin in a complex that has a molecular weight of approximately 320 kD. The serum concentration of sTfR is directly proportional to the concentration of the receptor on cell membranes.

The function of the transferrin receptor is to take up the iron transported to the cell by transferrin and bring it into the cell. About 80% of transferrin receptors are localized on precursor cells of erythropoiesis. Erythrocytes are excluded. In any functional iron deficiency, that is, insufficient availability of iron for erythropoiesis, the number of receptors on the membrane is upregulated.

Since the transferrin receptors are continuously detached from the cell membrane and pass into the plasma as soluble transferrin receptors (sTfR), the concentration of sTfR in serum is an indicator of the iron supply to erythropoiesis. However, this serum concentration is not only determined by the receptor density, but also by the number of erythroblasts.

In the case of iron deficiency, the sTfR concentration increases even before there is a significant drop in the hemoglobin concentration. The sTfR concentration can therefore be used to describe the functional iron status, while ferritin provides an indication of the iron depot status.

DiagnosisThis section has been translated automatically.

Detection method (particle-enhanced immunological turbidity test): Human soluble transferrin receptor agglutinated with latex particles coated with anti-soluble transferrin receptor antibody. The precipitate is determined photometrically.

Note(s)This section has been translated automatically.

Serum concentrations of sTfR are not affected by inflammatory conditions as are those of ferritin or transferrin.

Last updated on: 01.07.2022